Understanding Variability in Myasthenia Gravis
NeuroFrontiersUnderstanding Variability in Myasthenia Gravis
Henry Kaminski, MD
Examining the Global Genetic Prevalence of TK2d
NeuroFrontiersExamining the Global Genetic Prevalence of TK2d
Brian P. McDonough, MD, FAAFP
Austin Larson, MD
Microglia Drive Neurodegeneration in Friedreich’s Ataxia
NeuroFrontiersMicroglia Drive Neurodegeneration in Friedreich’s Ataxia
Ryan Quigley
Unpacking the Genetics of Friedreich’s Ataxia
NeuroFrontiersUnpacking the Genetics of Friedreich’s Ataxia
Arnulf Koeppen, MD
Friedreich’s Ataxia: Impact of Frataxin Loss
NeuroFrontiersFriedreich’s Ataxia: Impact of Frataxin Loss
Arnulf Koeppen, MD
- advertisement
- 3 questions
- advertisement
From Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Medical Industry FeatureFrom Monoamines to Neurocircuits: Our Evolving Understanding of Depression
Charles Turck, PharmD, BCPS, BCCCP
Joseph Goldberg, MD
Neuroplasticity: A Potential Target for the Treatment of Depression
Medical Industry FeatureNeuroplasticity: A Potential Target for the Treatment of Depression
Charles Turck, PharmD, BCPS, BCCCP
Madhukar H. Trivedi, MD
Breakthrough Technology Improves Concussion Assessment and Player Safety
Medical Industry FeatureBreakthrough Technology Improves Concussion Assessment and Player Safety
Thomas S. Bottiglieri, DO
Anti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Medical Industry FeatureAnti-Amyloid Therapy in Early Alzheimer’s Disease: Real-World Experience and Innovation
Marwan Sabbagh, MD, FAAN, CCR
Cara Leahy, DO
David Weisman, MD
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry FeatureAgitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
George Grossberg, MD
Angela Sanford, MD, CMD
Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Medical Industry FeatureTau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers
Yuval Zabar, MD
Michelle Mielke, PhD
Henrik Zetterberg, MD, PhD
- 05/04/2026
- 05/01/2026
- 05/01/2026
- 04/30/2026
- 04/28/2026
- 04/28/2026